Cargando…
The effect of dipeptidyl peptidase IV on disease-associated microglia phenotypic transformation in epilepsy
BACKGROUND: Accumulating evidence suggests that disease-associated microglia (DAM), a recently discovered subset of microglia, plays a protective role in neurological diseases. Targeting DAM phenotypic transformation may provide new therapeutic options. However, the relationship between DAM and epil...
Autores principales: | Zheng, Zhicheng, Liang, Peiyu, Hou, Baohua, Lu, Xin, Ma, Qianwen, Yu, Xiaomin, Han, Song, Peng, Biwen, Chen, Taoxiang, Liu, Wanhong, Yin, Jun, He, Xiaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114532/ https://www.ncbi.nlm.nih.gov/pubmed/33975617 http://dx.doi.org/10.1186/s12974-021-02133-y |
Ejemplares similares
-
Blockade of Kv1.3 Potassium Channel Inhibits Microglia-Mediated Neuroinflammation in Epilepsy
por: Zhang, Xinyi, et al.
Publicado: (2022) -
TRPV1 channel mediates NLRP3 inflammasome-dependent neuroinflammation in microglia
por: Zhang, Yahui, et al.
Publicado: (2021) -
Tackling dipeptidyl peptidase IV in neurological disorders
por: Al-Badri, Ghaith, et al.
Publicado: (2018) -
Dipeptidyl Peptidase IV as a Muscle Myokine
por: Kluess, Heidi A.
Publicado: (2020) -
Angioedema associated with dipeptidyl peptidase-IV inhibitors
por: Cassano, Nicoletta, et al.
Publicado: (2021)